Search Results - "Niogret, Julie"
-
1
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
Published in Journal for immunotherapy of cancer (01-06-2021)“…BackgroundT follicular helper cells (Tfh) are essential to shape B cell response during germinal center formation. Tfh accumulation has been reported in…”
Get full text
Journal Article -
2
Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life
Published in Frontiers in oncology (07-03-2022)“…Non-small-cell lung cancer (NSCLC) is one of the main causes of death by cancer worldwide. With the rise of targeted therapies, the search for molecular…”
Get full text
Journal Article -
3
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes
Published in Molecular cancer (29-07-2023)“…Non-small cell lung cancer is a very poor prognosis disease. Molecular analyses have highlighted several genetic alterations which may be targeted by specific…”
Get full text
Journal Article -
4
Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series
Published in International journal of molecular sciences (19-03-2022)“…Low-grade serous carcinoma represents a minority of serous carcinoma. Although they have better prognosis than high-grade serous carcinoma, they respond poorly…”
Get full text
Journal Article -
5
Improving olaparib exposure to optimize adverse effects management
Published in Therapeutic advances in medical oncology (01-01-2024)“…Olaparib is an inhibitor of the human poly-(ADP-ribose)-polymerase enzymes (PARP1/2) needed to repair single-strand DNA breaks. It is used in breast, ovarian,…”
Get full text
Journal Article -
6
Implementation and use of whole exome sequencing for metastatic solid cancer
Published in EBioMedicine (01-01-2020)“…Genomically-guided clinical trials are performed across different tumor types sharing genetic mutations, but trial organization remains complex. Here we…”
Get full text
Journal Article -
7
Primary Resistance to Afatinib in a Patient with Lung Adenocarcinoma Harboring Uncommon EGFR Mutations: S768I and V769L
Published in Journal of thoracic oncology (01-07-2018)Get more information
Journal Article -
8
Associated Factors to Efficacy and Tolerance of Immunotherapy in Older Patients with Cancer Aged 70 Years and Over: Impact of Coprescriptions
Published in Drugs & aging (01-09-2023)“…Background Immunotherapy with immune checkpoint blockers (ICB) significantly improves the prognosis for an increasing number of cancers. However, data on…”
Get full text
Journal Article -
9
The challenge of ovarian cancer care in the oldest old
Published in Cancer epidemiology (05-11-2024)“…Ovarian cancer (OC) is the eighth most common cancer in women, with a poor prognosis, particularly in older women. The aim of this study was to describe an…”
Get full text
Journal Article -
10
Phase II of desynchronized irinotecan plus bevacizumab, oxaliplatin, 5-fluorouracil, and folinic acid (bFOLFIRINOX-3) administration in chemorefractory metastatic colorectal cancer patients
Published in Journal of clinical oncology (01-06-2023)“…e15563 Background: In chemorefractory metastatic colorectal cancer (mCRC), targeted therapy such as TAS-102 and regorafenib have shown a modest survival…”
Get full text
Journal Article -
11
PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports
Published in Molecular medicine reports (01-01-2021)“…Loss‑of‑function BRCA mutations are frequent in high‑grade serous ovarian carcinoma. BRCA1 and ‑2 mutations lead to homologous recombination (HR) deficiency…”
Get full text
Journal Article -
12
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience
Published in Cancers (01-01-2024)“…Chemotherapy using carboplatin and etoposide (CE) is frequently pragmatically proposed to treat metastatic prostate cancer (mPC), both primary small-cell…”
Get full text
Journal Article -
13
Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?
Published in Lung cancer (Amsterdam, Netherlands) (01-11-2021)“…•Large Next Generation Sequencing (LNGS) is feasible in routine practice.•LNGS identified at least one potential molecular target in 74.4% of patients.•LNGS do…”
Get full text
Journal Article -
14
EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma
Published in World journal of gastrointestinal oncology (15-04-2018)“…Pancreatic acinar cell carcinoma (PACC) is a rare cancer. When the tumor is metastatic, few therapeutic options are available. Precision medicine using…”
Get full text
Journal Article -
15
EGFR amplification induces sensitivity to anti EGFR therapy in pancreatic acinar cell carcinoma
Published in World journal of gastrointestinal oncology (15-04-2018)“…Pancreatic acinar cell carcinoma (PACC) is a rare cancer. When the tumor is metastatic, few therapeutic options are available. Precision medicine using…”
Get full text
Journal Article -
16
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma
Published in Cancers (01-06-2020)“…Background: Predictive biomarkers of response to chemotherapy plus antiangiogenic for metastatic colorectal cancer (mCRC) are lacking. The objective of this…”
Get full text
Journal Article -
17
-
18